All PPMS subjects’ findings differed from the HCs in the percentage of CD4+CD25+high, CD4+CD25+, and surface expression of CD4+CD25+highFOXP3+ and CD4+CD25+FOXP3+ (Table 2). This evidence concerns the gene FOXP3 and primary progressive multiple sclerosis.